All News about Catalyst Pharm Inc
![](https://ml.globenewswire.com/media/960a6989-9f9c-4ad2-91cf-be10cebd6655/small/catalyst-pharmaceutical-logo.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_3.png?width=1200&height=800&fit=crop)
5 Analysts Have This to Say About Catalyst Pharmaceuticals
August 11, 2023
Via Benzinga
![](https://ml.globenewswire.com/media/960a6989-9f9c-4ad2-91cf-be10cebd6655/small/catalyst-pharmaceutical-logo.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_2.jpeg?width=1200&height=800&fit=crop)
Where Catalyst Pharmaceuticals Stands With Analysts
July 21, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_2.jpeg?width=1200&height=800&fit=crop)
The Latest Analyst Ratings for Catalyst Pharmaceuticals
June 21, 2023
Via Benzinga
![](/next-assets/images/schema-image-default.png)
Catalyst Pharmaceuticals: Q1 Earnings Insights
May 10, 2023
Via Benzinga
![](https://investorplace.com/wp-content/uploads/2022/10/valuestocks_1600_04.jpg)
![](https://ml.globenewswire.com/media/960a6989-9f9c-4ad2-91cf-be10cebd6655/small/catalyst-pharmaceutical-logo.jpg)
![](https://ml.globenewswire.com/media/960a6989-9f9c-4ad2-91cf-be10cebd6655/small/catalyst-pharmaceutical-logo.jpg)
![](https://ml.globenewswire.com/media/960a6989-9f9c-4ad2-91cf-be10cebd6655/small/catalyst-pharmaceutical-logo.jpg)
![](https://investorplace.com/wp-content/uploads/2020/04/stockstobuy1600_12.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/06/28/etf_movers.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_3.png?width=1200&height=800&fit=crop)
![](https://ml.globenewswire.com/media/960a6989-9f9c-4ad2-91cf-be10cebd6655/small/catalyst-pharmaceutical-logo.jpg)
![](https://investorplace.com/wp-content/uploads/2022/10/stocks-to-buy-greedy1600-1024x576.png)
![](https://ml.globenewswire.com/media/960a6989-9f9c-4ad2-91cf-be10cebd6655/small/catalyst-pharmaceutical-logo.jpg)
![](https://ml.globenewswire.com/media/960a6989-9f9c-4ad2-91cf-be10cebd6655/small/catalyst-pharmaceutical-logo.jpg)
![](https://g.foolcdn.com/editorial/images/733049/frustrated-investor-at-computers.jpg)
![](https://www.investors.com/wp-content/uploads/2016/06/ibd.jpg)
![](https://www.investors.com/wp-content/uploads/2022/06/Stock-RoadSigns-adobe.jpg)
![](https://www.investors.com/wp-content/uploads/2023/01/Stock-catalystpharma-firdapse-01-company.jpg)
![](https://ml.globenewswire.com/media/960a6989-9f9c-4ad2-91cf-be10cebd6655/small/catalyst-pharmaceutical-logo.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/05/11/groupon_-_logo_0.jpg?width=1200&height=800&fit=crop)
![](https://ml.globenewswire.com/media/960a6989-9f9c-4ad2-91cf-be10cebd6655/small/catalyst-pharmaceutical-logo.jpg)
![](https://ml.globenewswire.com/media/960a6989-9f9c-4ad2-91cf-be10cebd6655/small/catalyst-pharmaceutical-logo.jpg)
![](https://ml.globenewswire.com/media/960a6989-9f9c-4ad2-91cf-be10cebd6655/small/catalyst-pharmaceutical-logo.jpg)
![](https://ml.globenewswire.com/media/960a6989-9f9c-4ad2-91cf-be10cebd6655/small/catalyst-pharmaceutical-logo.jpg)
![](https://investorplace.com/wp-content/uploads/2019/07/stocks-to-buy-9.jpg)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.